BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15758980)

  • 1. Epigenetics: surveillance team against cancer.
    Klein G
    Nature; 2005 Mar; 434(7030):150. PubMed ID: 15758980
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetics and imprinting.
    Bachmann N; Bergmann C
    Arch Pediatr; 2012 Nov; 19(11):1145-7. PubMed ID: 23083687
    [No Abstract]   [Full Text] [Related]  

  • 3. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic changes in cancer.
    Iacobuzio-Donahue CA
    Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetics of oral cancer.
    Shaw R
    Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation as a regulatory mechanism for gene expression in mammals.
    Serman A; Vlahović M; Serman L; Bulić-Jakus F
    Coll Antropol; 2006 Sep; 30(3):665-71. PubMed ID: 17058541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and ovarian cancer.
    Nephew KP; Balch C; Zhang S; Huang TH
    Cancer Treat Res; 2009; 149():131-46. PubMed ID: 19763434
    [No Abstract]   [Full Text] [Related]  

  • 8. Excavating relics of DNA methylation changes during the development of neoplasia.
    Hsiao SH; Huang TH; Leu YW
    Semin Cancer Biol; 2009 Jun; 19(3):198-208. PubMed ID: 19429484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
    Kaneda A; Feinberg AP
    Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrotransposon-specific DNA hypomethylation and two-step loss-of-imprinting during WW45 haploinsufficiency-induced hepatocarcinogenesis.
    Song JY; Lee JH; Joe CO; Lim DS; Chung JH
    Biochem Biophys Res Commun; 2011 Jan; 404(2):728-34. PubMed ID: 21163252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer. Developing molecular biomarkers for cancer.
    Ransohoff DF
    Science; 2003 Mar; 299(5613):1679-80. PubMed ID: 12637728
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epigenetics--cellular memories--affect disease development].
    Ohlsson R; Göndor A
    Lakartidningen; 2006 Mar 22-28; 103(12):919-25. PubMed ID: 16618035
    [No Abstract]   [Full Text] [Related]  

  • 13. [Genomic imprinting and problem of parthenogenesis in mammals].
    Platonov ES
    Ontogenez; 2005; 36(4):300-9. PubMed ID: 16208941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
    Spandidos DA
    J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How an imprint can lead to cancer.
    Secko D
    CMAJ; 2005 May; 172(10):1286. PubMed ID: 15883399
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epigenetic changes in malignant cells].
    Hackanson B; Lübbert M
    Dtsch Med Wochenschr; 2011 Mar; 136(10):475-9. PubMed ID: 21365524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epigenetics-related diseases and analytic methods].
    Soejima H
    Rinsho Byori; 2009 Aug; 57(8):769-78. PubMed ID: 19764412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers.
    Valinluck V; Sowers LC
    Cancer Res; 2007 Jun; 67(12):5583-6. PubMed ID: 17575120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuclear atypia and epigenetic change].
    Ichimura T; Ito T
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2049-51. PubMed ID: 17471907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.